Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assistance Publique - Hôpitaux de Paris
As second objectives, the study aims to:
* Evaluate the GFR decline in patients who had an underlying chronic kidney disease.
* Evaluate factors associated with a persistent decreased GFR at day-90.
* Characterization the clinical and biological phenotype of chronic renal disease in these patients.
* Evaluate treatments provided to these patients according to CKD occurence.
* Evaluate the rate of cardiovascular and thrombo-embolic morbidity-mortality.
* Assess the quality of life every year for 3 years.
* Evaluate the medico-economic burden of CKD.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient ⩾ 18 years;
Patient suffering an acute kidney injury (defined by AKIN score ⩾1) during ICU stay;
Patient discharged alive from the ICU;
Patient's signed consent obtained;
Patient covered by a healthcare insurance.
You may not be if
Pregnant or breastfeeding woman;
SOFA score \< 1 (except for kidney assessment) at time of ICU admission;
End-stage of renal failure or dialysis treatment or renal transplantation prior to ICU admission;
Patient treated with dialysis at ICU discharge;
Immunosuppressive treatment prior to ICU admission;
Patient under legal incapacity (tutor or guardian protection);
Being unable to follow-up of the study;
Life expectancy expected shorter than 90 days;
Refusal to participate in the study;
Patient's main address is outside of Il de France region for the centers in this region;
Patient \< 18 years;
Patient not affiliated to national social security scheme;
Patient deprived of liberty by judicial measure.
Clareo Health | Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit
